📰 Pratik Multani News

Pratik Multani News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pratik Multani. Real-time updates on events, politics, business and more.

Initial Phase 1 Dose Escalation Data for ORIC-533 in Relapsed/Refractory Multiple Myeloma Demonstrates Clinical Activity and Strong Safety Profile Supporting Potential for Combination Development

December 11, 2023

Preliminary evidence of clinical antimyeloma activity, including reduction in paraprotein, demonstrated in multiple patients Clean safety profile with only Grade 1 and 2 treatment related adverse...

South San Francisco United States San Diego Jacobm Chacko Pratik Multani Dominic Piscitelli

Source: marketscreener.com

Initial Phase 1 Dose Escalation Data of ORIC-114 in

October 21, 2023

CNS activity observed at multiple dose levels, including the first reported confirmed CNS complete response by an EGFR exon 20 inhibitor in a patient with...

United States South San Francisco San Diego Pratik Multani Jacobm Chacko Securities Exchange

Source: globenewswire.com

Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profile

October 21, 2023

CNS activity observed at multiple dose levels, including the first reported confirmed CNS complete response by an EGFR exon 20 inhibitor in a patient with documented untreated brain metastases ...

United States South San Francisco San Diego Pratik Multani Jacobm Chacko Dominic Piscitelli

Source: marketscreener.com

Why ORIC Pharmaceuticals Stock Is Crashing Today

March 22, 2022

The company discontinued development of its lead clinical program.

Pratik Multani Biotechnology Innovation Organization Biotechnology Innovation

Source: fool.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation